Revolutionary Genomic Test Diagnoses Any Infection in One Step

A genomic test developed at UC San Francisco, using metagenomic next-generation sequencing (mNGS), can rapidly diagnose a wide range of pathogens, including viruses, bacteria, fungi, and parasites. This test, which has been successful in identifying 86% of neurological infections, offers a significant advancement in diagnosing diseases like meningitis and encephalitis. It also holds potential for early detection of new viral pandemics. The test, now automated for faster results, has received FDA breakthrough device designation and is expected to become a critical tool in clinical diagnostics.